Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stereotaxis, Inc. Common Stock (NY:STXS)

3.045 +0.055 (+1.84%)
Streaming Delayed Price Updated: 11:50 AM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Stereotaxis, Inc. Common Stock

< Previous 1 2 3 Next >
New Robotic System Promises Faster, Safer Care For Arrhythmia Patients
Stereotaxis (AMEX: STXS) announces first procedures with Genesis Robotic Magnetic Navigation System for minimally invasive endovascular interventions. 
Via Benzinga
Stereotaxis Inc (NYSEARCA:STXS) Q2 2025 Earnings: Revenue Surpasses Forecasts, Losses Narrower Than Expected
Stereotaxis Inc (NYSE:STXS) Q2 2025 earnings beat revenue estimates with $8.8M, narrowing losses to -$0.05 EPS. Stock rose 1.83% post-announcement. 
Via Chartmill
Topics Earnings
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Earnings Scheduled For May 12, 2025
 
Via Benzinga
What's Going On With Stereotaxis Shares Wednesday?
Stereotaxis shares are moving higher on Wednesday after the company announced it was accepted into the NVIDIA Connect program. 
Via Benzinga
Earnings Scheduled For March 3, 2025
 
Via Benzinga
Stereotaxis Earnings Preview
 
Via Benzinga
Earnings Scheduled For November 11, 2024
 
Via Benzinga
STXS Stock Earnings: Stereotaxis Misses EPS, Misses Revenue for Q2 2024
STXS stock results show that Stereotaxis missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Hyliion Holdings And 3 Other Penny Stocks Insiders Are Buying
 
Via Benzinga
STXS Stock Earnings: Stereotaxis Meets EPS, Misses Revenue for Q1 2024
STXS stock results show that Stereotaxis met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Recap: Stereotaxis Q4 Earnings
 
Via Benzinga
Earnings Preview For Stereotaxis
 
Via Benzinga
Recap: Stereotaxis Q3 Earnings
 
Via Benzinga
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here. 
Via InvestorPlace
7 Penny Stocks That Could 5X by the End of 2024
These seven penny stocks to buy have the potential to 5X your money by the end of 2024 if the right catalysts unfold. 
Via InvestorPlace
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Earnings Scheduled For March 4, 2024
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Insiders Buying Eyenovia And 3 Other Stocks Under $2
The Dow Jones closed lower by around 80 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Stereotaxis Clocks 28% Revenue Growth In Q2 On Continued Demand For Robotic Technology
Stereotaxis, Inc. (AMEX: STXS) reported Q2 revenues of $7.859 million,  
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781. 
Via Benzinga
US Stocks Mixed; Dow Gains 50 Points
U.S. stocks traded mixed this morning, with Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.16% to 34,464.01 while the NASDAQ fell 0.14% to... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Crude Oil Down 1%; Foot Locker Earnings Miss Expectations
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 100 points on Friday. The Dow traded down 0.42% to 33,393.85 while the NASDAQ fell 0.40% to 12,637.90. The S&P 500,... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.